1,631
Views
42
CrossRef citations to date
0
Altmetric
ARTICLES

Threat, Efficacy, and Uncertainty in the First 5 Months of National Print and Electronic News Coverage of the H1N1 Virus

, , &
Pages 338-355 | Published online: 21 Dec 2011
 

Abstract

The authors conducted a content analysis, investigating the first 5 months of national print and electronic news coverage of the H1N1 virus. They collected all stories about H1N1 appearing in 6 national news outlets between April and September 2009. Of these stories meeting the analysis criteria, the authors randomly selected 200 for inclusion. Using models of fear appeal message processing, this study investigated the nature and prevalence of threat and efficacy messages in news coverage of the virus. Such models have traditionally been applied to strategic health message contexts (e.g., campaigns) rather than to health news coverage. Results suggest that most stories made reference to the threat of the H1N1 virus, sometimes overemphasizing and sensationalizing virus-related death. With regard to efficacy, approximately half mentioned actions individuals or organizations/communities could take to protect themselves from the virus, but almost none provided evidence that such methods are effective, and some explicitly questioned their effectiveness. In addition, a number of stories referenced uncertainty about the threat of the virus (38%) and/or solutions to the potential threat (18%). The authors discuss the implications from the perspective of fear appeal message processing models.

Notes

Note. CDC = Centers for Disease Control; FDA = Food and Drug Administration; WHO = World Health Organization.

1We chose to use formation on the CDC website, as it sets a standard and should be used by all health agencies consistently.

2Accordingly, if the story equally used both terms, it received a score of 0; if it made more references to H1N1, it received a positive score, and if it made more references to swine flu, it received a negative score.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.